Synteract Acquires Dermatology Specialist CRO Cu-Tech


Applied Clinical Trials

Synteract, a CRO providing full-service Phase I-IV clinical trials, has acquired Cu-Tech, a dermatology specialist CRO. With this acquirement, Synteract has created a dedicated center of dermatology development.

Read the full release here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.